Skip to main content

Table 3 Allelic frequency for selected polymorphisms as segregated according to the progression in IMT measurements during a two-year period

From: A possible role for CCR5 in the progression of atherosclerosis in HIV-infected patients: a cross-sectional study

Allele

Non-progressors

Progressors

P-value

CXC3CR-1 249 V

0.61

0.50

NS

CXC3CR-1 280 M

0.10

0.12

NS

CCR2 62 I

0.07

0.08

NS

CCR5 Δ32

0.03

0.08

0.08